Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II randomized controlled trial to evaluate the supportive effect of Koujin (TJ-3020) powder in gemcitabine and nab-paclitaxel-treated unresectable or recurrent pancreatic cancer.
Otsu T, Takami H, Yamada S, Nakatochi M, Fujita K, Tashiro M, Hayashi M, Nakagawa N, Kurimoto K, Tanaka H, Kinoshita F, Kuwatsuka Y, Kodera Y. Otsu T, et al. Among authors: kuwatsuka y. Pancreas. 2024 Dec 2. doi: 10.1097/MPA.0000000000002446. Online ahead of print. Pancreas. 2024. PMID: 39626189
Identification of an interaction between VWF rs7965413 and platelet count as a novel risk marker for metabolic syndrome: an extensive search of candidate polymorphisms in a case-control study.
Nakatochi M, Ushida Y, Yasuda Y, Yoshida Y, Kawai S, Kato R, Nakashima T, Iwata M, Kuwatsuka Y, Ando M, Hamajima N, Kondo T, Oda H, Hayashi M, Kato S, Yamaguchi M, Maruyama S, Matsuo S, Honda H. Nakatochi M, et al. Among authors: kuwatsuka y. PLoS One. 2015 Feb 3;10(2):e0117591. doi: 10.1371/journal.pone.0117591. eCollection 2015. PLoS One. 2015. PMID: 25646961 Free PMC article.
Effect of dietary energy and polymorphisms in BRAP and GHRL on obesity and metabolic traits.
Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S. Imaizumi T, et al. Among authors: kuwatsuka y. Obes Res Clin Pract. 2018 Jan-Feb;12(Suppl 2):39-48. doi: 10.1016/j.orcp.2016.05.004. Epub 2016 May 27. Obes Res Clin Pract. 2018. PMID: 27245511
Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers.
Imaizumi T, Ando M, Nakatochi M, Maruyama S, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Matsuo S. Imaizumi T, et al. Among authors: kuwatsuka y. Clin Exp Nephrol. 2017 Jun;21(3):457-464. doi: 10.1007/s10157-016-1315-3. Epub 2016 Aug 1. Clin Exp Nephrol. 2017. PMID: 27480094
Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.
Kubo Y, Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kikuchi K, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S. Kubo Y, et al. Among authors: kuwatsuka y. PLoS One. 2017 Oct 10;12(10):e0185476. doi: 10.1371/journal.pone.0185476. eCollection 2017. PLoS One. 2017. PMID: 29016630 Free PMC article.
Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial.
Kanda M, Shimizu D, Miyata K, Maeda O, Tanaka C, Inokawa Y, Hattori N, Hayashi M, Ando M, Kuwatsuka Y, Murotani K, Nakayama G, Koike M, Ando Y, Ebata T, Kodera Y. Kanda M, et al. Among authors: kuwatsuka y. Contemp Clin Trials Commun. 2021 Nov 9;24:100853. doi: 10.1016/j.conctc.2021.100853. eCollection 2021 Dec. Contemp Clin Trials Commun. 2021. PMID: 34820548 Free PMC article.
Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma.
Mizutani Y, Iida T, Ohno E, Ishikawa T, Kinoshita F, Kuwatsuka Y, Imai M, Shimizu S, Tsuruta T, Enomoto A, Kawashima H, Fujishiro M. Mizutani Y, et al. Among authors: kuwatsuka y. BMC Cancer. 2022 Feb 24;22(1):205. doi: 10.1186/s12885-022-09272-2. BMC Cancer. 2022. PMID: 35209871 Free PMC article.
Influence of background characteristics in responders of regenerative therapy by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence.
Yamanishi T, Ishizuka O, Shimizu S, Kobayashi Y, Kinoshita F, Yamamoto T, Mizokami A, Narimoto K, Toriyama K, Kamei Y, Kuwatsuka Y, Mizuno M, Gotoh M. Yamanishi T, et al. Among authors: kuwatsuka y. Low Urin Tract Symptoms. 2022 Jul;14(4):273-280. doi: 10.1111/luts.12433. Epub 2022 Feb 25. Low Urin Tract Symptoms. 2022. PMID: 35218150
Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy.
Tanaka A, Furuhashi K, Fujieda K, Maeda K, Saito S, Mimura T, Saka Y, Naruse T, Ishimoto T, Kosugi T, Kinoshita F, Kuwatsuka Y, Shimizu S, Nakai Y, Maruyama S. Tanaka A, et al. Among authors: kuwatsuka y. Front Med (Lausanne). 2022 May 27;9:883168. doi: 10.3389/fmed.2022.883168. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35692547 Free PMC article.
Tranexamic acid and blood loss in pancreaticoduodenectomy: TAC-PD randomized clinical trial.
Ishii K, Yokoyama Y, Yonekawa Y, Hayashi D, Kinoshita F, Kuwatsuka Y, Okuno M, Natsume S, Minami T, Sugawara G, Seita K, Sato F, Aoba T, Shimizu Y, Kurumiya Y, Maeda A, Yamaguchi R, Hiramatsu K, Ebata T. Ishii K, et al. Among authors: kuwatsuka y. Br J Surg. 2023 Jan 10;110(2):159-165. doi: 10.1093/bjs/znac382. Br J Surg. 2023. PMID: 36379883 Clinical Trial.
146 results